CEO Dr. Hanadie Yousef delivered a seminar at the Buck Institute as a distinguished guest speaker highlighting Juvena’s pioneering work in regenerative biologics and AI-driven drug discovery
Juvena Therapeutics presented JUV-161 and JUV-112, at ENDO2025, earning recognition from the Endocrine Society for innovation in metabolic and endocrine health